Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Juvenile Spondyloarthropathies
NCT00591201Phase 3Completed
- Sponsor
- Hospital General de México "Dr. Eduardo Liceaga"
- Start
- Jun 2002
- Primary completion
- Jun 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in juvenile spondyloarthritis (JSpA), sponsored by Hospital General de México "Dr. Eduardo Liceaga". Started Jun 2002; status: completed.
02
Drugs
infliximab
03
Conditions
juvenile spondyloarthritis (JSpA)
Beyond the preview
Go deeper on NCT00591201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591201.